Infertility Drugs Market Strategies, Top Players, and Forecast by 2031

Historic Data: 2021-2023   |   Base Year: 2024   |   Forecast Period: 2025-2031

Coverage: Infertility Drugs Market covers analysis by Drug Class (Ovulatory Stimulants, Selective Estrogen Receptor Modulators (SERMs), Biguanides, Dopamine Agonists, Tricyclic Antidepressants, Others); Gender (Male, Female); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) , and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Date : Aug 2025
  • Report Code : TIPRE00004428
  • Category : Life Sciences
  • Status : Upcoming
  • Available Report Formats : pdf-format excel-format
  • No. of Pages : 150

The Infertility Drugs Market is expected to register a CAGR of 6.2% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.

The Infertility Drugs Market report covers analysis by Drug Class (Ovulatory Stimulants, Selective Estrogen Receptor Modulators (SERMs), Biguanides, Dopamine Agonists, Tricyclic Antidepressants, Others); Gender (Male, Female); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Geography (North America, Europe, Asia Pacific, and South and Central America). The global analysis is further broken-down at regional level and major countries. The report Offers the Value in US$ for the above analysis and segments.

Purpose of the Report

The report Infertility Drugs Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:

  • Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
  • Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
  • Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.

Infertility Drugs Market Segmentation

Drug Class

  • Ovulatory Stimulants
  • Selective Estrogen Receptor Modulators
  • Biguanides
  • Dopamine Agonists
  • Tricyclic Antidepressants

Gender

  • Male
  • Female

Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Infertility Drugs Market: Strategic Insights

infertility-drugs-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Infertility Drugs Market Growth Drivers

  • Increasing incidence of infertility: Infertility rates are increasing worldwide, and this is attributed to delayed childbearing, lifestyle changes, environmental factors, and increased cases of conditions such as polycystic ovary syndrome (PCOS) and endometriosis. As infertility increases, the demand for infertility drugs, including ovulation stimulants, fertility boosters, and hormone treatments, has increased. This driver is propelling the growth of the infertility drugs market as more couples seek help to conceive.
  • Advancements in fertility treatments: Improvements in reproductive medicine and fertility treatment protocols are further accelerating the growth of the market for infertility drugs. Targeted drugs that enhance the chances of fertility, such as selective estrogen receptor modulators (SERMs), follicle-stimulating hormone (FSH) analogs, and human chorionic gonadotropin (hCG) preparations, have helped improve the outcomes of infertility treatments. These improvements increase the success rate of conception, which positively contributes to the growth of the market.
  • Rising awareness of fertility treatments: There has been a significant increase in awareness of fertility treatments among the public, including increased acceptance of assisted reproductive technologies (ART) and other infertility drugs. The more people are introduced to the availability and success rate of infertility treatments, such as IVF and hormone therapies, the greater the demand for fertility medications continues to be. Additionally, this trend is bolstered by educational campaigns, coverage of the issue through the media, and increased social openness around infertility issues.

Infertility Drugs Market Future Trends

  • Demand for personalized medicine: Personalized healthcare is increasing, and fertility treatments are becoming more and more specific for individual patients. Personalized fertility treatments based on a woman's age, reproductive health, hormone levels, and medical history need customized drug regimens. The trend of the development of more precise and effective infertility drugs that offer better outcomes and fewer side effects for patients is affecting the market by improving the efficiency of treatment.
  • Increased Attention to Women's Health: With increased awareness in society about women's reproductive health, there is a greater emphasis on enhancing women's fertility and treatments for conditions that affect fertility, such as PCOS and early menopause. This trend is driving research and development in the area of infertility drugs, including those that specifically address women's health concerns. The increasing focus on women's reproductive health is fueling the need for targeted therapies to manage and treat infertility effectively.
  • Rise of fertility tourism: Fertility tourism refers to the growing trend of people or couples traveling abroad to obtain infertility treatments that are either less expensive or more successful. The most popular fertility destinations include India, Spain, and the United States. Due to the global availability of fertility treatments, infertility drugs are in great demand worldwide, especially in areas with a large number of fertility tourists who come to these places in search of low-cost and successful treatments.

Infertility Drugs Market Opportunities

  • Development of novel drug formulations: New drugs are being designed to be able to improve fertility outcomes as much as possible while reducing their side effects as much as possible. Newer drug combinations targeted toward specific fertility-related issues, like ovulation disorder or male infertility, are gaining increasing attention. Long-acting injectables and oral medicines with fewer adverse effects are also predicted to gain a higher market. This opens an avenue for pharmaceutical companies to innovate and introduce new infertility drugs that are convenient and effective for patients.
  • Emphasis on treatments for male infertility: While much attention in infertility treatment has traditionally been directed towards female infertility, male infertility is increasingly recognized as a huge contributor to reproductive issues. One emerging opportunity in this regard is the development of drugs and treatments aimed at improving sperm quality and motility, which may include testosterone boosters and antioxidants. With the growing awareness about male infertility, the demand for infertility drugs focused on male reproductive health is likely to increase and provide new avenues for drug manufacturers.
  • Supportive government initiatives and policies: Government policies and initiatives to enhance access to fertility treatments and reproductive health are driving the growth of the infertility drugs market. In most countries, governments have introduced subsidies, insurance coverage, and financial assistance for infertility treatments, making fertility drugs more affordable and accessible. In addition, increasing awareness of infertility as a health issue is driving the establishment of national infertility programs, which further boosts market growth.

Infertility Drugs Market Regional Insights

The regional trends and factors influencing the Infertility Drugs Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Infertility Drugs Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

infertility-drugs-market-global-geography
  • Get the Regional Specific Data for Infertility Drugs Market

Infertility Drugs Market Report Scope

Report Attribute Details
Market size in 2024 US$ XX million
Market Size by 2031 US$ XX Million
Global CAGR (2025 - 2031) 6.2%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Drug Class
  • Ovulatory Stimulants
  • Selective Estrogen Receptor Modulators
  • Biguanides
  • Dopamine Agonists
  • Tricyclic Antidepressants
By Gender
  • Male
  • Female
By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Pfizer, Inc.
  • Takeda Pharmaceutical Company Limited
  • F. Hoffmann-La Roche Ltd
  • Merck KGaA
  • Eli Lilly and Company
  • Bayer AG
  • Novartis AG
  • Ferring B. V.
  • COOPER PHARMA LIMITED

  • Infertility Drugs Market Players Density: Understanding Its Impact on Business Dynamics

    The Infertility Drugs Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

    Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.

    Major Companies operating in the Infertility Drugs Market are:

    1. Pfizer, Inc.
    2. Takeda Pharmaceutical Company Limited
    3. F. Hoffmann-La Roche Ltd
    4. Merck KGaA
    5. Eli Lilly and Company
    6. Bayer AG

    Disclaimer: The companies listed above are not ranked in any particular order.


    infertility-drugs-market-cagr

    • Get the Infertility Drugs Market top key players overview

    Key Selling Points

    • Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Infertility Drugs Market, providing a holistic landscape.
    • Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
    • Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
    • Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.

    The research report on the Infertility Drugs Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.


    Frequently Asked Questions

    What are the major driving factors impacting the Infertility Drugs Market?

    The major factors driving the Infertility Drugs Market are Increasing incidence of infertility, Advancements in fertility treatments, and Rising awareness of fertility treatments

    What are the future trends of the Infertility Drugs Market?

    The key future trends of the market are Demand for personalized medicine, Increased Attention to Women's Health, and Rise of fertility tourism

    Which are the leading players operating in the Infertility Drugs Market?

    The leading players operating in the Infertility Drugs Market include Pfizer, Inc., Takeda Pharmaceutical Company Limited, F. Hoffmann-La Roche Ltd, Merck KGaA, Eli Lilly and Company, Bayer AG, Novartis AG, Ferring B. V., COOPER PHARMA LIMITED.

    What are the deliverable formats of Infertility Drugs Market report?

    The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.

    What are the options available for the customization of this report?

    Some of the customization options available based on the request are an additional 3–5 company profiles and country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.

    Mrinal Kerhalkar
    Mrinal Kerhalkar
    Manager,
    Market Research & Consulting

    Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

    Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset

    Testimonials

    user

    I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.

    DR CHIJIOKE ONYIA, MANAGING DIRECTOR, PineCrest Healthcare Ltd.
    user

    The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services

    Yukihiko Adachi CEO, Deep Blue, LLC.

    Reason to Buy

    • Informed Decision-Making
    • Understanding Market Dynamics
    • Competitive Analysis
    • Customer Insights
    • Market Forecasts
    • Risk Mitigation
    • Strategic Planning
    • Investment Justification
    • Identifying Emerging Markets
    • Enhancing Marketing Strategies
    • Boosting Operational Efficiency
    • Tracking Industry Innovations
    • Aligning with Regulatory Trends
    Your Key Concerns Addressed - Question & Answer
    Can I view a sample of the report before purchasing?

    Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.

    Is analyst support included with the purchase?

    Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.

    What are the next steps once I place an order?

    Once your order is successfully placed, you will receive a confirmation email along with your invoice.

    • For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
    • For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.

    Can the report be tailored to suit my specific needs?

    We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.

    In what format is the report delivered?

    The report is available in either PDF format or as an Excel dataset, depending on the license you choose.

    The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
    Please review the license options at checkout or contact us to confirm which formats are included with your purchase.

    How secure is the payment process on your platform?

    Our payment process is fully secure and PCI-DSS compliant.

    We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
    You can make your purchase with confidence, knowing your personal and financial information is safe with us.

    Do you provide special pricing for buying multiple reports?

    Yes, we do offer special pricing for bulk purchases.
    If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.

    Can I connect with your team to discuss the report before buying?

    Yes, absolutely.
    Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.

    Will I get a billing invoice upon purchase?

    Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
    If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.

    Is there support available if I can’t access my report?

    Yes, certainly.
    If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.

    Our Clients
    The List of Companies

    1. Pfizer, Inc.
    2. Takeda Pharmaceutical Company Limited
    3. F. Hoffmann-La Roche Ltd
    4. Merck KGaA
    5. Eli Lilly and Company
    6. Bayer AG
    7. Novartis AG
    8. Ferring B. V.
    9. COOPER PHARMA LIMITED
    10. senechio Pharma Pvt. Ltd.
    Sales Assistance
    US: +1-646-491-9876
    UK: +44-20-8125-4005
    Email: sales@theinsightpartners.com
    Chat with us
    DUNS Logo
    87-673-9708
    ISO Certified Logo
    ISO 9001:2015
    ISO Certified Logo